Cercar
01/05/2023
Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice
Soler-Vazquez, MC, Romero, MD, Todorcevic, M, Delgado, K, Calatayud, C, Benitez-Amaro, A, Lhoest, MTL, Mera, P, Zagmutt, S, Bastias-Perez, M, Ibeas, K, Casals, N, Escola-Gil, JC, Llorente-Cortes, V, Consiglio, A, Serra, D, Herrero, L. Implantation of CPT1AM-expressing adipocytes reduces obesity and glucose intolerance in mice. METABOLIC ENGINEERING. 2023; 77DOI:10.1016/j.ymben.2023.04.010. PMID:37088334. IF:6.800(Q1/1D).
04/04/2023
SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression
Villanueva-Carmona, T, Cedo, L, Madeira, A, Ceperuelo-Mallafre, V, Rodriguez-Pena, MM, Nunez-Roa, C, Maymo-Masip, E, Repolles-de-Dalmau, M, Badia, J, Keiran, N, Mirasierra, M, Pimenta-Lopes, C, Sabadell-Basallote, J, Bosch, R, Caubet, L, Escola-Gil, JC, Fernandez-Real, JM, Vilarrasa, N, Ventura, F, Vallejo, M, Vendrell, J, Fernandez-Veledo, S. SUCNR1 signaling in adipocytes controls energy metabolism by modulating circadian clock and leptin expression. Cell Metabolism. 2023; 35(4)DOI:10.1016/j.cmet.2023.03.004. PMID:36977414. IF:27.700(Q1/1D).
01/01/2023
Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor
Ferrer R., Mansilla A., Tondo M., Blanco-Vaca F.. Remnant cholesterol: new outcomes highlight its potential as a clinically useful cardiovascular risk factor. Journal Of Laboratory And Precision Medicine. 2023; 8DOI:10.21037/jlpm-22-70. PMID:. IF:(Q/D).
01/01/2022
MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses
Martos-Folgado I., del Monte-Monge A., Lorenzo C., Busse C.E., Delgado P., Mur S.M., Cobos-Figueroa L., Escolà-Gil J.C., Martín-Ventura J.L., Wardemann H., Ramiro A.R.. MDA-LDL vaccination induces athero-protective germinal-center-derived antibody responses. Cell Reports. 2022; 41(2)DOI:10.1016/j.celrep.2022.111468. PMID:36223741. IF:8.800(Q1/2D).
06/05/2022
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression
Simoes, AM, Holmstrom, MO, Aehnlich, P, Rahbech, A, Radziwon-Balicka, A, Zamora, C, Klausen, TW, Skov, V, Kjaer, L, Ellervik, C, El Fassi, D, Vidal, S, Hasselbalch, HC, Andersen, MH, Straten, PT. Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression. Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.866610. PMID:35603202. IF:7.300(Q1/3D).
01/12/2021
Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease
Isola, I, Moreno, DF, Moga, E, Mena, MP, Tovar, N, Rodriguez-Lobato, LG, Oliver-Caldes, A, Salgado, MC, Braso-Maristany, F, Yague, J, Cibeira, MT, Prat, A, Rosinol, L, Blade, J, de Larrea, CF. Immunoparesis defined by heavy/light chain pair suppression in smoldering multiple myeloma shows initial isotype specificity and involves other isotypes in advanced disease. ANNALS OF HEMATOLOGY. 2021; 100(12)DOI:10.1007/s00277-021-04653-2. PMID:34463804. IF:4.030(Q2/5D).
01/12/2021
Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review
d'Alessandro, M, Bergantini, L, Bargagli, E, Vidal, S. Extracellular Vesicles in Pulmonary Fibrosis Models and Biological Fluids of Interstitial Lung Disease Patients: A Scoping Review. Life-Basel. 2021; 11(12)DOI:10.3390/life11121401. PMID:34947932. IF:3.253(Q2/5D).
07/09/2021
The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome (vol 7, 12288, 2021)
Vidal, S, Brandi, N, Pacheco, P, Gerotina, E, Blasco, L, Trotta, JR, Derdak, S, O'Callaghan, MD, Garcia-Cazorla, A, Pineda, M, Armstrong, J, Cortes, R., Gallano P., Villar, Cristina. The utility of Next Generation Sequencing for molecular diagnostics in Rett syndrome (vol 7, 12288, 2021). Scientific Reports. 2021; 11(1)DOI:10.1038/s41598-021-97262-y. PMID:34493777. IF:4.997(Q2/3D).
10/09/2025
Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline
Park, HS, del Campo, PD, Plana, MN, La Borda, JPY, Guerra-Rodriguez, M, Moreno, M, Cañete, JD. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Frontiers in Medicine. 2025; 12DOI:10.3389/fmed.2025.1621313. PMID:41001393. IF:3.000(Q1/2D).
18/06/2025
Laboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey
Aguado, R, Irure-Ventura, J, Vargas, ML, Roy, G, Barrios, Y, Martínez-Martínez, L, Rodríguez, B, Montes-Cano, MA, López-Hoyos, M, Jurado, A. Laboratory and Clinical Practices in the Study of Coeliac Disease in Children and Adults: Recommendations from a Spanish Multicentre Survey. Nutrients. 2025; 17(12)DOI:10.3390/nu17122032. PMID:40573143. IF:5.000(Q1/2D).
01/06/2025
RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM
Ruiz-Esquide, V, Roig-Vilaseca, D, Mateo-Soria, L, Pérez, SH, Nack, A, Perez-Garcia, C, Park, HS, Paños, HB, Gómez-Puerta, JA, Sanmarti, R. RACE/ETHNICITY AND RHEUMATOID ARTHRITIS SEVERITY IN THE CONTEXT OF AN ACCESSIBLE PUBLIC HEALTHCARE SYSTEM. ANNALS OF THE RHEUMATIC DISEASES. 2025; 84DOI:10.1136/annrheumdis-2025-eular.B2454. PMID:. IF:20.600(Q1/1D).
01/10/2024
OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY
Buddingh, EP, Slatter, M, Becerra, JCA, Garcia, LA, von Asmuth, E, Baris, S, de la Calle-Mart n, O, Chan, A, Chan, B, Chandrakasan, S, Chellapandian, D, Dara, J, Landsverk, HCE, Farmand, S, Fasth, A, Forbes, L, Formankova, R, Grunebaum, E, Keogh, S, Kiykim, A, K hl, JS, Laberko, A, Lankester, A, Leahy, TR, Lindemans, C, Martinez, C, Mart nez-Mart nez, L, Mitchell, WG, Morris, E, Neven, B, Oved, J, Prazenicova, M, Riviere, JG, Roifman, C, G ltekin, SSK, Sedlacek, P, Shah, A, Vong, L, Leiding, J, Sch tz, C. OUTCOME OF PATIENTS WITH SIGNAL-TRANSDUCER AND ACTIVATOR OF OF TRANSCRIPTION 1 MUTATIONS (STAT1) GAIN-OF-FUNCTION VARIANTS AFTER HAEMATOPOIETIC STEM CELL TRANSPLANTATION - AN IEWP/PIDTC STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).
01/09/2024
Serum calprotectin in severe and mild COVID-19 patients
Agulló, GJ, Aragon, MP, de la Poza, JFD, Alcorisa, SV. Serum calprotectin in severe and mild COVID-19 patients. EUROPEAN JOURNAL OF IMMUNOLOGY. 2024; 54DOI:. PMID:. IF:3.700(Q2/5D).
12/01/2024
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
Staniek, J, Kalina, T, Andrieux, G, Boerries, M, Janowska, I, Fuentes, M, Diez, P, Bakardjieva, M, Stancikova, J, Raabe, J, Neumann, J, Schwenk, S, Arpesella, L, Stuchly, J, Benes, V, Valiente, RG, Garcia, JF, Carsetti, R, Mortari, EP, Catala, A, de la Calle, O, Sogkas, G, Neven, B, Rieux-Laucat, F, Magerus, A, Neth, O, Olbrich, P, Voll, RE, Alsina, L, Allende, LM, Gonzalez-Granado, LI, Boehler, C, Thiel, J, Venhoff, N, Lorenzetti, R, Warnatz, K, Unger, S, Seidl, M, Mielenz, D, Schneider, P, Ehl, S, Rensing-Ehl, A, Smulski, CR, Rizzi, M. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells. Science Immunology. 2024; 9(91)DOI:10.1126/sciimmunol.adj5948. PMID:38215192. IF:16.300(Q1/1D).
01/10/2023
Inherited human ezrin deficiency impairs adaptive immunity
García-Solís B., Van Den Rym A., Martinez-Martínez L., Franco T., Pérez-Caraballo J.J., Markle J., Cubillos-Zapata C., Marín A.V., Recio M.J., Regueiro J.R., Navarro-Zapata A., Mestre-Durán C., Ferreras C., Martín Cotázar C., Mena R., de la Calle-Fabregat C., López-Lera A., Fernández Arquero M., Pérez-Martínez A., López-Collazo E., Sánchez-Ramón S., Casanova J.-L., Martínez-Barricarte R., de la Calle-Martín O., Pérez de Diego R.. Inherited human ezrin deficiency impairs adaptive immunity. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2023; 152(4)DOI:10.1016/j.jaci.2023.05.022. PMID:37301410. IF:11.400(Q1/1D).
17/05/2023
Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey
Martinez-Martinez, L, Irure-Ventura, J, Jurado, A, Roy, G, Montes, MA, Barrios, Y, Rodriguez-Bayona, B, Vergara, E, Prada, A, Rojo, R, Vargas, ML. Laboratory and clinical practices in antinuclear antibody detection and related antigens: recommendations from a Spanish multicentre survey. IMMUNOLOGIC RESEARCH. 2023; 71(5)DOI:10.1007/s12026-023-09389-x. PMID:37195550. IF:3.300(Q3/6D).
19/04/2023
Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated bla(IMI-6) Gene
Blanco-Martin, T, Guzman-Puche, J, Riazzo, C, Gasca-Santiyan, M, Hernandez-Garcia, M, Canton, R, Torre-Cisneros, J, Herrera, C, Martinez-Martinez, L. Phenotypic and Molecular Characterization of an Enterobacter ludwigii Clinical Isolate Carrying a Plasmid-Mediated bla(IMI-6) Gene. Microbiology Spectrum. 2023; 11(3)DOI:10.1128/spectrum.04620-22. PMID:37074170. IF:3.700(Q2/4D).
05/08/2022
Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression (vol 13, 866610, 2022)
Simoes, AMC, Holmstrom, MO, Aehnlich, P, Rahbech, A, Peeters, MJW, Radziwon-Balicka, A, Zamora, C, Klausen, TW, Skov, V, Kjaer, L, Ellervik, C, El Fassi, D, Vidal, S, Hasselbalch, HC, Andersen, MH, Straten, PT. Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression (vol 13, 866610, 2022). Frontiers in Immunology. 2022; 13DOI:10.3389/fimmu.2022.970322. PMID:35990670. IF:7.300(Q1/3D).
01/11/2025
Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study
Puente, A, Turón, F, Martínez, J, Fortea, JI, Guerra, MH, Alvarado, E, Pons, M, Magaz, M, Llop, E, Alvarez-Navascués, C, Navarrete, AA, Berenguer, M, Masnou, H, Bañares, R, Casado, M, Ampuero, J, Rios, J, Saavedra, C, Blasi, A, Lisman, T, Figuero, CR, Huelin, P, Tellez, L, Arráez, DM, Rodriguez, M, Aguilera, V, Loste, MTA, Baiges, A, Hernandez-Gea, V, Perelló, C, Calleja, JL, Genescà, J, Villanueva, C, Gonzalez-Alayón, C, Albillos, A, Crespo, J, Garcia-Pagán, JC. Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study. JOURNAL OF HEPATOLOGY. 2025; 83(5)DOI:10.1016/j.jhep.2025.06.035. PMID:40691992. IF:33.000(Q1/1D).
06/02/2025
DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders
Lessel, I, Baresic, A, Chinn, IK, May, J, Goenka, A, Chandler, KE, Posey, JE, Afenjar, A, Averdunk, L, Bedeschi, MF, Besnard, T, Brager, R, Brick, L, Brugger, M, Brunet, T, Byrne, S, de la Calle-Martín, O, Capra, V, Cardenas, P, Chappé, C, Chong, HJ, Cogne, B, Conboy, E, Cope, H, Courtin, T, Deb, W, Dilena, R, Dubourg, C, Elgizouli, M, Fernandes, E, Fitzgerald, KK, Gangi, S, George-Abraham, JK, Gucsavas-Calikoglu, M, Haack, TB, Hadonou, M, Hanker, B, Hüning, I, Iascone, M, Isidor, B, Järvelä, I, Jin, JJ, Jorge, AAL, Josifova, D, Kalinauskiene, R, Kamsteeg, EJ, Keren, B, Kessler, E, Kölbel, H, Kozenko, M, Kubisch, C, Kuechler, A, Leal, SM, Leppälä, J, Luu, SM, Lyon, GJ, Madan-Khetarpal, S, Mancardi, M, Marchi, E, Mehta, L, Menendez, B, Morel, CF, Harasink, SM, Nevay, DL, Nigro, V, Odent, S, Oegema, R, Pappas, J, Pastore, MT, Perilla-Young, Y, Platzer, K, Powell-Hamilton, N, Rabin, R, Rekab, A, Rezende, RC, Robert, L, Romano, F, Scala, M, Poths, K, Schrauwen, I, Sebastian, J, Short, J, Sidlow, R, Sullivan, J, Szakszon, K, Tan, QKG, Wagner, M, Wieczorek, D, Yuan, B, Maeding, N, Strunk, D, Begtrup, A, Banka, S, Lupski, JR, Tolosa, E, Lessel, D. DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders. AMERICAN JOURNAL OF HUMAN GENETICS. 2025; 112(2)DOI:10.1016/j.ajhg.2024.12.012. PMID:39798569. IF:8.100(Q1/1D).